22 U.S.C. § 7612a — HIV/AIDS Working Capital Fund

submitted 22 years ago by Pub. L. 108-447 to r/title-22-FOREIGN-RELATIONS-AND-INTERCOURSE · 441 words · no verdicts yet

in plain englishAI-generated · not legal advice

This law lets the U.S. Global AIDS Coordinator set up a Working Capital Fund to buy HIV/AIDS medicines and supplies. Other federal agencies can pay into the Fund, and the Coordinator must report yearly to Congress on how it's used.

(1) The Coordinator of United States Government Activities to Combat HIV/AIDS Globally may create an "HIV/AIDS Working Capital Fund." Its purpose is to help build a safe, secure, reliable, and lasting supply chain of medicines and other products for treating people with HIV/AIDS and related infections, in line with section 2151b–2. (2) Money put into the Fund in any year does not expire — it can be used without a time limit. It must go toward medicine and products for HIV/AIDS care and treatment, including: anti-retroviral drugs; other medicines and medical items for care and treatment; lab and other supplies for related testing; other medical supplies for running HIV/AIDS treatment centers, including programs that stop mothers from passing HIV to their babies; medicines and health supplies for palliative (comfort) care; and lab and clinical equipment, plus equipment for transporting and storing HIV/AIDS supplies and other equipment for prevention, care, and treatment. (3) Other federal agencies — including USAID, Health and Human Services, and the Department of Defense — can pay into the Fund for HIV/AIDS supplies they receive from it, at actual cost, actual cost plus extra fees, or another price the Coordinator agrees to. (4) The Fund can also receive payments for lost or damaged supplies, rebates, reimbursements, refunds, and similar credits related to running the Fund. (5) At the end of each fiscal year, the Coordinator may move money out of the Fund to other HIV/AIDS program areas, if the Coordinator decides the Fund has more than it needs. (6) At the end of each fiscal year, the Coordinator must send the Appropriations Committees a report detailing the Fund's finances, including where its money came from and how it was spent.

the actual law source: uscode.house.gov ↗public domain

(1)

In furtherance of the purposes of section 2151b–2 of this title, and to assist in providing a safe, secure, reliable, and sustainable supply chain of pharmaceuticals and other products needed to provide care and treatment of persons with HIV/AIDS and related infections, the Coordinator of the United States Government Activities to Combat HIV/AIDS Globally (the “Coordinator”) is authorized to establish an HIV/AIDS Working Capital Fund (in this section referred to as the “HIV/AIDS Fund”).

(2)

Funds deposited during any fiscal year in the HIV/AIDS Fund shall be available without fiscal year limitation and used for pharmaceuticals and other products needed to provide care and treatment of persons with HIV/AIDS and related infections, including, but not limited to—

(A)

anti-retroviral drugs;

(B)

other pharmaceuticals and medical items needed to provide care and treatment to persons with HIV/AIDS and related infections;

(C)

laboratory and other supplies for performing tests related to the provision of care and treatment to persons with HIV/AIDS and related infections;

(D)

other medical supplies needed for the operation of HIV/AIDS treatment and care centers, including products needed in programs for the prevention of mother-to-child transmission;

(E)

pharmaceuticals and health commodities needed for the provision of palliative care; and

(F)

laboratory and clinical equipment, as well as equipment needed for the transportation and care of HIV/AIDS supplies, and other equipment needed to provide prevention, care and treatment of HIV/AIDS described above.

(3)

There may be deposited during any fiscal year in the HIV/AIDS Fund payments for HIV/AIDS pharmaceuticals and products provided from the HIV/AIDS Fund received from applicable appropriations and funds of the United States Agency for International Development, the Department of Health and Human Services, the Department of Defense, or other Federal agencies and other sources at actual cost of the HIV/AIDS pharmaceuticals and other products, actual cost plus the additional costs of providing such HIV/AIDS pharmaceuticals and other products, or at any other price agreed to by the Coordinator or his designee.

(4)

There may be deposited in the HIV/AIDS Fund payments for the loss of, or damage to, HIV/AIDS pharmaceuticals and products held in the HIV/AIDS Fund, rebates, reimbursements, refunds and other credits applicable to the operation of the HIV/AIDS Fund.

(5)

At the close of each fiscal year the Coordinator may transfer out of the HIV/AIDS Fund to other HIV/AIDS programmatic areas such amounts as the Coordinator determines to be in excess of the needs of the HIV/AIDS Fund.

(6)

At the close of each fiscal year the Coordinator shall submit a report to the Committees on Appropriations detailing the financial activities of the HIV/AIDS Fund, including sources of income and information regarding disbursements.

Source credit: (Pub. L. 108–447, div. D, title V, § 525(b), Dec. 8, 2004, 118 Stat. 3000.)

history & why it existsrecord from the source credit

2004Enacted · Pub. L. 108-447 · 118 Stat. 3000

A history note hasn’t been published yet. The record shows enactment by Pub. L. 108-447 on 2004-12-08.

all 0 arguments · sorted by: best

no arguments yet — make the first case